Coefficient | p Value (95% CI) | |||
Estimate | Standard error | z | ||
Duration of infliximab | −0.03 | 0.01 | −3.51 | <0.001 (−0.05 to −0.01) |
DAS28 | −0.02 | 0.14 | −0.13 | 0.897 (−0.30 to 0.26) |
Heart rate | 0.06 | 0.02 | 2.92 | 0.003 (0.02 to 0.10) |
Systolic BP | 0.02 | 0.01 | 1.30 | 0.195 (−0.01 to 0.04) |
Triglycerides | 0.48 | 0.40 | 1.22 | 0.221 (−0.29 to 1.27) |
Constant | 2.42 | 2.24 | 1.08 | 0.282 (−1.98 to 6.81) |
σu | 1.26 | |||
σe | 0.99 | |||
Rho | 0.62 |
Number of observations = 59, number of groups = 26, R2 overall 0.4129.
BP, blood pressure; DAS, disease activity score.